
Rob Wiblin on self-improvement and research ethics
80,000 Hours Podcast
Rethinking FDA Regulations
This chapter explores the need for enhanced FDA regulations regarding medical treatments, advocating for clearer labeling and better reporting on non-approved drugs. It argues for a balance between patient autonomy and safety, emphasizing informed consent and the complexities of drug evaluation processes.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.